MiNK Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
MiNK Therapeutics Total Assets Growth & History (INKT)
MiNK Therapeutics's total assets was $14.2M for fiscal 2025.
View full MiNK Therapeutics company overviewMiNK Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.2M | $8.5M | +148.90% |
| 2024 | 2024-12-31 | $5.7M | $1.2M | +25.67% |
| 2023 | 2023-12-31 | $4.6M | −$16.9M | −78.80% |
| 2022 | 2022-12-31 | $21.5M | −$18.8M | −46.64% |
| 2021 | 2021-12-31 | $40.2M | $35.7M | +783.42% |
| 2020 | 2020-12-31 | $4.6M | — | — |
MiNK Therapeutics quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.6M | $7.1M | +287.02% |
| Q1 2026 | 2026-03-31 | $10.4M | $6.1M | +143.17% |
| Q4 2025 | 2025-12-31 | $14.2M | $8.5M | +148.90% |
| Q3 2025 | 2025-09-30 | $15.0M | $7.6M | +102.90% |
| Q2 2025 | 2025-06-30 | $2.5M | −$7.8M | −75.93% |
| Q1 2025 | 2025-03-31 | $4.3M | −$2.6M | −38.10% |
| Q4 2024 | 2024-12-31 | $5.7M | $1.2M | +25.67% |
| Q3 2024 | 2024-09-30 | $7.4M | −$86,870 | −1.16% |
| Q2 2024 | 2024-06-30 | $10.3M | −$1.8M | −14.76% |
| Q1 2024 | 2024-03-31 | $6.9M | −$9.7M | −58.44% |
| Q4 2023 | 2023-12-31 | $4.6M | −$16.9M | −78.80% |
| Q3 2023 | 2023-09-30 | $7.5M | −$17.8M | −70.46% |
| Q2 2023 | 2023-06-30 | $12.1M | −$19.0M | −61.08% |
| Q1 2023 | 2023-03-31 | $16.6M | −$19.6M | −54.10% |
| Q4 2022 | 2022-12-31 | $21.5M | −$18.8M | −46.64% |
| Q3 2022 | 2022-09-30 | $25.3M | $21.2M | +519.56% |
| Q2 2022 | 2022-06-30 | $31.1M | — | — |
| Q1 2022 | 2022-03-31 | $36.1M | — | — |
| Q4 2021 | 2021-12-31 | $40.2M | $35.7M | +783.42% |
| Q3 2021 | 2021-09-30 | $4.1M | — | — |
| Q4 2020 | 2020-12-31 | $4.6M | — | — |
MiNK Therapeutics total assets trends
Over the last five fiscal years, MiNK Therapeutics's total assets increased from $4.6M to $14.2M, a change of $9.7M. The latest reported quarter, Q2 2026, shows $9.6M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MiNK Therapeutics source filings ↗